CZT心脏专用SPECT心肌血流定量技术临床应用中国专家共识
Chinese expert consensus on the clinical application of CZT cardiac-dedicated SPECT myocardial blood flow quantification technique
余飞 1李剑明 2张涵 1刘海燕 3武萍 3何薇 4尚华 5肖俊杰 6贠明凯 7李殿富 8张晓丽 7李思进3
作者信息
- 1. 同济大学核医学研究所,同济大学附属第十人民医院核医学科,上海 200040
- 2. 泰达国际心血管病医院核医学科,天津 300457
- 3. 山西医科大学第一医院核医学科,太原 030001
- 4. 复旦大学附属华东医院核医学科,上海 200040
- 5. 河北医科大学第二医院核医学科,石家庄 050000
- 6. 上海大学心血管研究所,上海器官修复工程技术研究中心,上海 200444
- 7. 首都医科大学附属北京安贞医院核医学科,北京 100069
- 8. 南京医科大学附属第一医院心血管内科,南京 210029
- 折叠
摘要
PET/CT心肌血流量(MBF)定量技术被认为是目前无创评估MBF和心肌血流储备(MFR)的"金标准",但由于受正电子心肌灌注显像药物获取困难等多种因素的限制,该技术在我国临床实践工作中开展的并不理想.采用全新半导体碲锌镉(CZT)探测器的心脏专用SPECT定量技术近些年在国内逐步开展,可实现定量评估MBF和MFR.本专家共识介绍了CZT心脏专用SPECT MBF定量技术的相关药物准备、具体步骤及其在临床应用中所提供的诊断与预后价值,希望有助于进一步规范和推广该技术在国内的应用.
Abstract
PET/CT myocardial blood flow(MBF)quantification technique is currently considered to be the'gold standard'for non-invasive assessment of MBF and myocardial flow reserve(MFR).Nevertheless,due to various limitations such as difficulties in obtaining positron-emitting myocardial perfusion imaging agents,this technique is not well developed in clinical practice in China.The cardiac-dedicated SPECT MBF quantification technique equipped with a new semiconductor cadmium zinc telluride(CZT)detector has been used in clinical practice in China recently,which can provide quantitative assessment of MBF and MFR.This expert consensus introduces the related medication preparation,acquisition protocols,and the diagnostic and prognostic value of CZT-dedicated SPECT MBF quantitative technology in clinical applications,which in order to further regulate and promote its application in China.
关键词
体层摄影术,发射型计算机,单光子/心肌灌注显像/碲锌镉/心肌血流量/心肌血流储备Key words
Tomography,emission computed,single-photon/Myocardial perfusion imaging/Cadmium zinc telluride/Myocardial blood flow/Myocardial flow reserve引用本文复制引用
出版年
2024
NETL
NSTL
万方数据